Lucy Therapeutics
Cambridge
About Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria. The company is offering a differentiated approach to drug discovery by drugging targets associated with early disease pathogenesis. The company's approach can also be expanded to provide new options for treating similar neurologically focused diseases including Parkinson's Disease (PD) and Alzheimer's Disease (AD).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $38.5M
- Last round: Series Unknown (May 2024)
- Website: lucytherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lucy-therapeutics-105243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.